MedPath

Predictive Accuracy of PLR and PNR in Detecting ETIC

Recruiting
Conditions
Trauma Injury
Coagulopathy
Registration Number
NCT07046858
Lead Sponsor
Jubilee Mission Medical College and Research Institute
Brief Summary

Observational study to know what is the predictive accuracy of platelet-neutrophil ratio (PNR) and platelet-lymphocyte ratio (PLR) done in patients presenting to ED( emergency department)within 6 hours of trauma; in detecting early trauma induced coagulopathy during hospital admission

Detailed Description

Trauma has a significant impact on the wellbeing and healthcare for the populations. Millions of patients seek medical help as a result of trauma, with a substantial proportion of patients suffering from life-changing or life-limiting injuries. The leading cause of traumatic death worldwide is road traffic collision, followed by suicide and homicide.(4) The role of platelets in the hemostasis and coagulation is crucial. Platelet interaction with lymphocytes, neutrophils, and monocytes modifies both the innate and adaptive immune responses.Platelets stick to the damaged endothelium and recruit leukocytes to the sites of injury.

Lymphocytes are the major cellular components of the humoral and cell-mediated immune system which include T, B, and natural killer cells. Platelet-lymphocyte ratio (PLR), platelet- neutrophil ratio (PNR) could reflect the balance between the body response to inflammation and immunity mediators Previously, few studies have tested the usefulness of PLR, PNR for predicting the outcomes in stroke , cardiovascular diseases. abdominal trauma, ARDS (Acute Respiratory Distress Syndrome) \& sepsis. I would like to do a study, where the results could be utilized in a resource limited hospital , for early referral and the prognostic value of these biomarkers in predicting ETIC in trauma.

The present study hypothesize that the on-admission PLR , PNR values would help early risk stratification and timely management of trauma patients which subsequently improve the outcomes

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
250
Inclusion Criteria
  • All patients with trauma AND
  • Presenting to ED within 6 hours of the event AND
  • The ED Physician sends coagulation profile
Exclusion Criteria
  • Treated with intravenous fluids, drugs, whole blood and blood products elsewhere
  • Patients admitted with a non-mechanical mechanism of injury, specifically drowning, hanging,or burns, as these mechanisms may result in a different biologic response than mechanical trauma
  • Patients on known medications affecting coagulation profile or hemogram
  • Patients with known chronic liver disease, chronic renal failure, malignancy, hematological disorders
  • Patients not consenting for the study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Sensitivity, specificity, positive and negative predictive value24 hours

PLR and PNR ratio in predicting in-hospital transfusion requirement during index hospital admission.

Secondary Outcome Measures
NameTimeMethod
Compare the AUROC of PLR and PNR ratio in predicting prolonged ventilatory support (>21 days)24 hours

Prolonged ventilators support

Compare the AUROC ( Area Under the Receiver Operating Characteristic Curve) of PLR and PNR ratio in predicting in-hospital transfusion requirement during index hospital admission24 hours

PLR and PNR ratio in predicting in-hospital 30 day mortality

Compare the incidence of emergent surgery, renal replacement therapy amongst patients developing ETIC and those who do not during the duration of hospital stay or within 30 days (whichever is earlier)24hours

Renal replacement therapy in patients with ETIC

Compare the length of hospital stay, total number of surgeries, total intensive care days in numbers amongst patients developing ETIC and those who do not during the duration of hospital stay or within 30 days (whichever is earlier)24hours

length of hospital stay, total number of surgeries, total intensive care days in numbers amongst patients developing ETIC and those who do not during the duration of hospital stay or within 30 days

Trial Locations

Locations (1)

Jubilee Mission Medical College

🇮🇳

Thrissur, Kerala, India

Jubilee Mission Medical College
🇮🇳Thrissur, Kerala, India
Dr Siju V Abraham, MBBS MD
Contact
+91 94477 54321
sijuvabraham@gmail.com
Dr Amrutha T, MBBS
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.